Xiaoqi Liu
Xiaoqi Liu
Professor, Department of Biochemistry, Purdue University
Verified email at
Cited by
Cited by
Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness
S Yue, J Li, SY Lee, HJ Lee, T Shao, B Song, L Cheng, T Masterson, X Liu, ...
Cell Metabolism 19, 393-406, 2014
Polo-like kinase (Plk) 1 depletion induces apoptosis in cancer cells
X Liu, RL Erikson
Proceedings of the National Academy of Sciences 100 (10), 5789-5794, 2003
Normal cells, but not cancer cells, survive severe Plk1 depletion
X Liu, M Lei, RL Erikson
Molecular and cellular biology 26 (6), 2093-2108, 2006
Plk1 inhibitors in cancer therapy: from laboratory to clinics
REA Gutteridge, MA Ndiaye, X Liu, N Ahmad
Molecular cancer therapeutics 15 (7), 1427-1435, 2016
Activation of Cdc2/cyclin B and inhibition of centrosome amplification in cells depleted of Plk1 by siRNA
X Liu, RL Erikson
Proceedings of the National Academy of Sciences 99 (13), 8672-8676, 2002
Inhibition of Notch signaling promotes browning of white adipose tissue and ameliorates obesity
P Bi, T Shan, W Liu, F Yue, X Yang, XR Liang, J Wang, J Li, N Carlesso, ...
Nature medicine, 2014
The MAP kinase pathway is required for entry into mitosis and cell survival
X Liu, S Yan, T Zhou, Y Terada, RL Erikson
Oncogene 23 (3), 763-776, 2004
Hypoxia promotes satellite cell self-renewal and enhances the efficiency of myoblast transplantation
W Liu, Y Wen, P Bi, X Lai, XS Liu, X Liu, S Kuang
Development 139 (16), 2857-2865, 2012
A role for Plk1 phosphorylation of NudC in cytokinesis
T Zhou, JP Aumais, X Liu, LY Yu-Lee, RL Erikson
Developmental cell 5 (1), 127-138, 2003
Targeting Polo-like kinases: a Promising Therapeutic Approach for Cancer Treatment
X Liu
Translational Oncology 8 (3), 185-195, 2015
Peripheral Golgi protein GRASP65 is a target of mitotic polo-like kinase (Plk) and Cdc2
CY Lin, ML Madsen, FR Yarm, YJ Jang, X Liu, RL Erikson
Proceedings of the National Academy of Sciences 97 (23), 12589-12594, 2000
Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1)
J Tang, RL Erikson, X Liu
Proceedings of the National Academy of Sciences 103 (32), 11964-11969, 2006
The role of polo-like kinase 1 in carcinogenesis: cause or consequence?
BD Cholewa, X Liu, N Ahmad
Cancer research 73 (23), 6848-6855, 2013
Plk1-dependent phosphorylation regulates functions of DNA topoisomerase IIα in cell cycle progression
H Li, Y Wang, X Liu
Journal of Biological Chemistry 283 (10), 6209-6221, 2008
Polo‐like kinase 1 phosphorylation of G2 and S‐phase‐expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery
XS Liu, H Li, B Song, X Liu
EMBO reports 11 (8), 626-632, 2010
Plk1-mediated phosphorylation of Topors regulates p53 stability
X Yang, H Li, Z Zhou, WH Wang, A Deng, O Andrisani, X Liu
Journal of Biological Chemistry 284 (28), 18588-18592, 2009
Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1
X Liu, T Zhou, R Kuriyama, RL Erikson
Journal of cell science 117 (15), 3233-3246, 2004
Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer
B Song, XS Liu, SJ Rice, S Kuang, BD Elzey, SF Konieczny, TL Ratliff, ...
Molecular cancer therapeutics 12 (1), 58-68, 2013
Resveratrol, in its natural combination in whole grape, for health and disease management
C Singh, X Liu, N Ahmad
Annals of The New York Academy of Sciences 1348, 150-160, 2015
Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer
Z Zhang, X Hou, C Shao, J Li, JX Cheng, S Kuang, N Ahmad, T Ratliff, ...
Cancer Research 74, 6635-6647, 2014
The system can't perform the operation now. Try again later.
Articles 1–20